Robert Jan Veldman

2.1k total citations
29 papers, 1.8k citations indexed

About

Robert Jan Veldman is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Robert Jan Veldman has authored 29 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Cell Biology. Recurrent topics in Robert Jan Veldman's work include Sphingolipid Metabolism and Signaling (16 papers), Lipid Membrane Structure and Behavior (10 papers) and Drug Transport and Resistance Mechanisms (8 papers). Robert Jan Veldman is often cited by papers focused on Sphingolipid Metabolism and Signaling (16 papers), Lipid Membrane Structure and Behavior (10 papers) and Drug Transport and Resistance Mechanisms (8 papers). Robert Jan Veldman collaborates with scholars based in Netherlands, France and United States. Robert Jan Veldman's co-authors include Wim J. van Blitterswijk, Marcel Verheij, Jannie Borst, Arnold H. van der Luit, Thierry Levade, Jan Kok, Karin Klappe, Hannie Sietsma, Robert Salvayre and Olivier Cuvillier and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and Circulation Research.

In The Last Decade

Robert Jan Veldman

28 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Jan Veldman Netherlands	20	1.4k	387	378	307	122	29	1.8k
Krishna R. Juluri United States	13	1.3k 0.9×	430 1.1×	378 1.0×	253 0.8×	159 1.3×	16	2.0k
Jean‐Pierre Jaffrézou France	29	2.1k 1.5×	388 1.0×	389 1.0×	451 1.5×	104 0.9×	45	2.7k
Valérie Gouazé‐Andersson France	20	1.3k 0.9×	271 0.7×	207 0.5×	277 0.9×	71 0.6×	31	1.6k
Tie-Yan Han United States	20	1.8k 1.3×	247 0.6×	202 0.5×	505 1.6×	94 0.8×	21	2.1k
Daniel Canals United States	27	1.6k 1.2×	438 1.1×	426 1.1×	128 0.4×	94 0.8×	48	2.0k
Yaakov Lavie Israel	22	1.5k 1.1×	647 1.7×	291 0.8×	556 1.8×	194 1.6×	26	2.0k
Yunxiang Zhu United States	22	1.0k 0.7×	578 1.5×	482 1.3×	87 0.3×	105 0.9×	43	1.7k
Paul A. Walton Canada	26	2.0k 1.4×	439 1.1×	423 1.1×	210 0.7×	84 0.7×	42	2.6k
Mary Lui United States	10	1.9k 1.4×	233 0.6×	287 0.8×	283 0.9×	114 0.9×	11	2.3k
Thomas D. Mullen United States	11	1.4k 1.0×	305 0.8×	302 0.8×	89 0.3×	100 0.8×	20	1.6k

Countries citing papers authored by Robert Jan Veldman

Since Specialization

Citations

This map shows the geographic impact of Robert Jan Veldman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Jan Veldman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Jan Veldman more than expected).

Fields of papers citing papers by Robert Jan Veldman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Jan Veldman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Jan Veldman. The network helps show where Robert Jan Veldman may publish in the future.

Co-authorship network of co-authors of Robert Jan Veldman

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Jan Veldman. A scholar is included among the top collaborators of Robert Jan Veldman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Jan Veldman. Robert Jan Veldman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vlasblom, Ronald, Mátyás A. Bittenbinder, Jon-Ruben van Rhijn, et al.. (2024). Distinct cardiotoxic effects by venoms of a spitting cobra (Naja pallida) and a rattlesnake (Crotalus atrox) revealed using an ex vivo Langendorff heart model. Toxicon. 240. 107637–107637.

Koppelman, Stef J., Monic M. M. Tomassen, Govardus A. H. de Jong, et al.. (2018). Release of Major Peanut Allergens from Their Matrix under Various pH and Simulated Saliva Conditions—Ara h2 and Ara h6 Are Readily Bio-Accessible. Nutrients. 10(9). 1281–1281. 16 indexed citations

Veldman, Robert Jan. (2014). Pretrial Detention in Kentucky: An Analysis of the Impact of House Bill 463 During the First Two Years of Its Implementation. Kentucky law journal. 102(3). 8. 1 indexed citations

Lummel, Menno van, Wim J. van Blitterswijk, Stefan R. Vink, et al.. (2010). Enriching lipid nanovesicles with short‐chain glucosylceramide improves doxorubicin delivery and efficacy in solid tumors. The FASEB Journal. 25(1). 280–289. 52 indexed citations

Vaessen, Stefan F.C., Robert Jan Veldman, Jolanda Snapper, et al.. (2009). AAV gene therapy as a means to increase apolipoprotein (Apo) A‐I and high‐density lipoprotein‐cholesterol levels: correction of murine ApoA‐I deficiency. The Journal of Gene Medicine. 11(8). 697–707. 14 indexed citations

Goldiner, Ilana, Astrid E. van der Velde, Zamir Halpern, et al.. (2006). ABCA1-dependent but apoA-I-independent cholesterol efflux mediated by fatty acid–bile acid conjugates (FABACs). Biochemical Journal. 396(3). 529–536. 18 indexed citations

Veldman, Robert Jan, Willem Reijnders, & Rob J. M. van Spanning. (2006). Specificity of FNR-type regulators in Paracoccus denitrificans. Biochemical Society Transactions. 34(1). 94–96. 10 indexed citations

Veldman, Robert Jan, Gerben A. Koning, Albert J. van Hell, et al.. (2005). Coformulated N-Octanoyl-glucosylceramide Improves Cellular Delivery and Cytotoxicity of Liposomal Doxorubicin. Journal of Pharmacology and Experimental Therapeutics. 315(2). 704–710. 29 indexed citations

Nierman, Melchior C., Berthil H.C.M.T. Prinsen, Jaap Rip, et al.. (2005). Enhanced Conversion of Triglyceride-Rich Lipoproteins and Increased Low-Density Lipoprotein Removal in LPLS447X Carriers. Arteriosclerosis Thrombosis and Vascular Biology. 25(11). 2410–2415. 19 indexed citations

10.

Vruchte, Daniëlle te, Emyr Lloyd‐Evans, Robert Jan Veldman, et al.. (2004). Accumulation of Glycosphingolipids in Niemann-Pick C Disease Disrupts Endosomal Transport. Journal of Biological Chemistry. 279(25). 26167–26175. 163 indexed citations

11.

Veldman, Robert Jan, Alain C. Mita, Olivier Cuvillier, et al.. (2003). The absence of functional glucosylceramide synthase does not sensitize melanoma cells for anticancer drugs. The FASEB Journal. 17(9). 1144–1146. 39 indexed citations

12.

Sietsma, Hannie, Robert Jan Veldman, & Jan Kok. (2001). The Involvement of Sphingolipids in Multidrug Resistance. The Journal of Membrane Biology. 181(3). 153–162. 68 indexed citations

13.

Morjani, Hamid, et al.. (2001). Elevation of glucosylceramide in multidrug-resistant cancer cells and accumulation in cytoplasmic droplets. International Journal of Cancer. 94(2). 157–165. 102 indexed citations

14.

Veldman, Robert Jan, et al.. (2001). A neutral sphingomyelinase resides in sphingolipid-enriched microdomains and is inhibited by the caveolin-scaffolding domain: potential implications in tumour necrosis factor signalling. Biochemical Journal. 355(3). 859–868. 89 indexed citations

15.

Filipeanu, Catalin M., Adriaan Nelemans, Robert Jan Veldman, Dick de Zeeuw, & Jan Willem Kok. (2000). Regulation of [Ca²⁺]_i homeostasis in MRP1 overexpressing cells. FEBS Letters. 474(1). 107–110. 10 indexed citations

16.

Rodrigues‐Lima, Fernando, Amanda Fensome, Michelle B. Josephs, et al.. (2000). Structural Requirements for Catalysis and Membrane Targeting of Mammalian Enzymes with Neutral Sphingomyelinase and Lysophospholipid Phospholipase C Activities. Journal of Biological Chemistry. 275(36). 28316–28325. 44 indexed citations

17.

Kok, Jan Willem, Robert Jan Veldman, Karin Klappe, et al.. (2000). Differential expression of sphingolipids in MRP1 overexpressing HT29 cells. International Journal of Cancer. 87(2). 172–178. 75 indexed citations

18.

Veldman, Robert Jan, Hannie Sietsma, Karin Klappe, Dick Hoekstra, & Jan Kok. (1999). Inhibition of P-Glycoprotein Activity and Chemosensitization of Multidrug-Resistant Ovarian Carcinoma 2780AD Cells by Hexanoylglucosylceramide. Biochemical and Biophysical Research Communications. 266(2). 492–496. 20 indexed citations

19.

Babià, Teresa, Robert Jan Veldman, Dick Hoekstra, & Jan Kok. (1998). Modulation of carcinoembryonic antigen release by glucosylceramide. European Journal of Biochemistry. 258(1). 233–242. 21 indexed citations

20.

Veldman, Robert Jan, et al.. (1998). Metabolism and apoptotic properties of elevated ceramide in HT29rev cells. Biochemical Journal. 331(2). 563–569. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact